CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Germin8 Ventures

Ashlie L Burkart, MD, CM, Chief Scientific Officer

The Next Frontier in Precision Nutrition

Ashlie L Burkart

Ashlie L Burkart

What should I eat to lose weight?  Is red meat good for you or bad? Will eating more broccoli prevent me from getting cancer?


Remember the old sayingyou are what you eat? It turns out, it would be more appropriate to say you are what you digest and metabolize. Human digestion is outsourced to the community of microbes housed in our GI tract called the microbiome. These microbes determine your blood sugar levels with meals (glycemic response), calories you derive from food, and modulate your food cravings, making some people more prone to obesity, diabetes, and other medical conditions.


Did you know you need the right bacteria to benefit from the anti-cancer effect of broccoli? Cruciferous vegetables like broccoli contain glucosinolates which are metabolized by gut bacteria into an anti-cancer metabolite called sulphoraphane - that is if you have the right bacteria. Since one person may benefit more than another based on the microbes present in the gut, the next time your child says I won’t eat my broccoli because I don’t have the right bacteria, science is on her side. However, replacing those missing bacteria isn’t so far away. Proof of concept is a lab in Singapore engineered bacteria that derived the anti-cancer benefits from broccoli and shrink tumors in mice.


There are various examples of how we digest and metabolize our food differently. Is red meat good or bad for you? It partly depends on your gut microbes – some microbiomes will produce higher levels of a pro-inflammatory compound called TMAO that has been linked to heart disease. What happens to the fiber you eat? Again, it depends on if you have bacteria that ferment more butyric acid (the main fuel source for the cells lining your colon) or compounds like propionic acid which are pro-inflammatory.


So how close are we to precision nutrition – to dropping the one size fits all diet and replacing it with customized diets based on an individual's genetics, disease state, microbiome, metabolome, etc.? Humans, microbiomes, food, and food culture are complex, and in order to progress forward, advancing our understanding in all 4 arenas are essential. All types of technology, not just computers, obey Moore’s laws doubling power.Twenty years ago, sequencing the first human genome was a colossal event that took 13 years and $1 billion dollars, and now we can sequence DNA for under $100 in less than a day. In a few years it will be within minutes for a few dollars, and perhaps on a device the size of your phone. 


Ten years ago, it was a challenge to know what organisms are in your microbiome, and today, we can determine which microbial genes are expressed and what metabolites are producing thanks to advances in sequencing technology, decreased costs, and improved machine learning for complex multi-omics.


Humans, microbiomes, food, and food culture are complex, and in order to progress forward, advancing our understanding in all 4 arenas are essential

 


Precision nutrition, in many ways parallels precision medicine but has some extra layers of complexity. For one, food is complex. We know less than 1percent of the compounds in plants alone, making 99 percent of what we eat “dark nutrition,” and Brightseed, a start-up company in Germin8 Venture’s portfolio, is using machine learning to discover unknown health-promoting phytonutrients. Moreover, food culture is complex. It is one thing to ask a patient to be compliant with taking a few pills and quite another to get people to change their way of eating. Add into the mix food deserts, budget and time restraints, and cultural eating habits.


Precision nutrition will be used to combat disease or pre-disease states, food sensitivities, weight issues, and metabolic issues. It will also be a tool to improve healthspan. At this time, if you are healthy and have an optimally functioning microbiome, the best way to make sure your body is getting the nutrients it needs is by incorporating a wide variety of whole foods rich with naturally occurring vitamins and minerals. The ideal diet is whole foods – vegetables, fruits, whole grains, meats, healthy fats. Daily supplements should be used to fill the gaps in conjunction with a healthy diet, and never in place of it. Ingredients matter, as most chronic diseases are linked to highly processed foods. Democratization of healthy food should be as important as access to healthcare. The 21st century health company will be an amalgam of digital health, precision medicine, precision nutrition, and therapeutics all in one. 


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/the-next-frontier-in-precision-nutrition--nwid-430.html